BENITEC LTD

Benitec Biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and life-threatening human diseases. Their transformational technology, ddRNAi, targets and ‘turns off’ specific genes related to disease, providing lasting treatment and potentially cure with a single dose. Compared to traditional approaches to RNA intereference, ddRNAi is easier to deliver, safer to us, more targeted and more efficient. Benitec has a pipeline of in-house and partnered dru... g development programs based on ddRNAI, including Hepatitis C and B, cancer-associated pain and drug-resistant lung cancer. Our Hepatitis C program is nearing clinical trials in 2013. ddRNAi has the potential to silence genes related to thousands of human diseases and is protected by over 40 global patents. The technology is available from Benitec under a variety of licence options.

#SimilarOrganizations #People #Financial #Website #More

BENITEC LTD

Social Links:

Twitter

Industry:

Biotechnology Genetics Health Diagnostics Medical Therapeutics

Founded:

2001-01-01

Address:

Hayward, California, United States

Country:

United States

Website Url:

http://www.benitec.com

Total Employee:

11+

Status:

Active

Contact:

4089602207

Email Addresses:

[email protected]

Total Funding:

57.99 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics